Aviral Jain

1.6k total citations
49 papers, 1.2k citations indexed

About

Aviral Jain is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Aviral Jain has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmaceutical Science, 18 papers in Molecular Biology and 15 papers in Biomaterials. Recurrent topics in Aviral Jain's work include Advanced Drug Delivery Systems (17 papers), Nanoparticle-Based Drug Delivery (14 papers) and RNA Interference and Gene Delivery (13 papers). Aviral Jain is often cited by papers focused on Advanced Drug Delivery Systems (17 papers), Nanoparticle-Based Drug Delivery (14 papers) and RNA Interference and Gene Delivery (13 papers). Aviral Jain collaborates with scholars based in India and Switzerland. Aviral Jain's co-authors include Sanjay Jain, Arvind Gulbake, Piush Khare, Vandana Soni, Yashwant Gupta, Manish K. Chourasia, Satish Shilpi, Ashish Jain, Pooja Hurkat and Mohini Chaurasia and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Solid State Communications and Journal of Physics and Chemistry of Solids.

In The Last Decade

Aviral Jain

46 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aviral Jain India 20 483 388 372 153 134 49 1.2k
Anekant Jain India 19 613 1.3× 483 1.2× 509 1.4× 171 1.1× 153 1.1× 25 1.5k
Upendra Kumar Jain India 20 330 0.7× 364 0.9× 402 1.1× 171 1.1× 101 0.8× 75 1.2k
Dina Nath Mishra India 14 708 1.5× 386 1.0× 402 1.1× 158 1.0× 96 0.7× 20 1.4k
Jülide Akbuğa Türkiye 25 578 1.2× 515 1.3× 470 1.3× 169 1.1× 135 1.0× 84 1.7k
Omathanu Perumal United States 19 380 0.8× 542 1.4× 312 0.8× 175 1.1× 179 1.3× 29 1.4k
Vivek K. Pawar India 20 556 1.2× 339 0.9× 376 1.0× 240 1.6× 110 0.8× 39 1.5k
Alaa Eldeen B. Yassin Saudi Arabia 19 618 1.3× 300 0.8× 276 0.7× 132 0.9× 131 1.0× 46 1.1k
Mohamed M. Badran Saudi Arabia 16 574 1.2× 258 0.7× 250 0.7× 127 0.8× 84 0.6× 37 1.0k
Glen Perera Austria 24 932 1.9× 415 1.1× 364 1.0× 97 0.6× 115 0.9× 32 1.4k
Raida Al‐Kassas New Zealand 19 818 1.7× 417 1.1× 389 1.0× 233 1.5× 128 1.0× 39 1.6k

Countries citing papers authored by Aviral Jain

Since Specialization
Citations

This map shows the geographic impact of Aviral Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aviral Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aviral Jain more than expected).

Fields of papers citing papers by Aviral Jain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aviral Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aviral Jain. The network helps show where Aviral Jain may publish in the future.

Co-authorship network of co-authors of Aviral Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Aviral Jain. A scholar is included among the top collaborators of Aviral Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aviral Jain. Aviral Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jain, Sanjay, et al.. (2016). Lactose-Conjugated PLGA Nanoparticles for Enhanced Delivery of Rifampicin to the Lung for Effective Treatment of Pulmonary Tuberculosis.. PubMed. 64(3). 278–87. 11 indexed citations
2.
Jain, Ankit, Ashish Jain, Aviral Jain, et al.. (2014). Targeted SLNs for management of HIV-1 associated dementia. Drug Development and Industrial Pharmacy. 41(8). 1321–1327. 12 indexed citations
3.
Jain, Ankita, Priyanka Jain, Darshana Jain, et al.. (2014). Novel Strategies for Effective Transdermal Drug Delivery: A Review. Critical Reviews in Therapeutic Drug Carrier Systems. 31(3). 219–272. 34 indexed citations
4.
Soni, Vandana, et al.. (2013). DEVELOPMENT OF MUCOADHESIVE BUCCAL PATCHES FOR CONTROLLED DELIVERY OF ANTI DIABETIC DRUG.
5.
Jain, Ashish, Aviral Jain, Satish Shilpi, et al.. (2013). Insulin delivery through nasal route using thiolated microspheres. Drug Delivery. 20(5). 210–215. 14 indexed citations
6.
Jain, Aviral & Sanjay Jain. (2013). Formulation and optimization of temozolomide nanoparticles by 3 factor 2 level factorial design. PubMed. 3(2). e25102–e25102. 25 indexed citations
7.
Jain, Ashish, Aviral Jain, Arvind Gulbake, et al.. (2013). Peptide and Protein Delivery Using New Drug Delivery Systems. Critical Reviews in Therapeutic Drug Carrier Systems. 30(4). 293–329. 108 indexed citations
8.
Jain, Ashish, Arvind Gulbake, Satish Shilpi, et al.. (2011). Mannosylated liposomes bearing Amphotericin B for effective management of visceral Leishmaniasis. Journal of Liposome Research. 21(4). 333–340. 26 indexed citations
9.
Jain, Amit, Arvind Gulbake, Ashish Jain, et al.. (2011). Development of surface-functionalised nanoparticles for FGF2 receptor-based solid tumour targeting. Journal of Microencapsulation. 29(1). 95–102. 13 indexed citations
10.
Bansal, Divya, et al.. (2010). Chondroitin sulfate functionalized liposomes for solid tumor targeting. Journal of drug targeting. 19(4). 251–257. 28 indexed citations
11.
Jain, Aviral, et al.. (2010). Transferrin-appended PEGylated nanoparticles for temozolomide delivery to brain:in vitrocharacterisation. Journal of Microencapsulation. 28(1). 21–28. 43 indexed citations
12.
Gulbake, Arvind, Aviral Jain, Piush Khare, & Sanjay Jain. (2009). Solid lipid nanoparticles bearing oxybenzone:In-vitroandin-vivoevaluation. Journal of Microencapsulation. 27(3). 2998652235–2998652235. 20 indexed citations
13.
Gulbake, Arvind, et al.. (2009). Targeted delivery of an anti-cancer agent via steroid coupled liposomes. Drug Delivery. 16(8). 437–447. 24 indexed citations
14.
Jain, Sanjay, et al.. (2008). Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery. Nanomedicine Nanotechnology Biology and Medicine. 4(1). 41–48. 113 indexed citations
15.
Jain, Aviral & Sanjay Jain. (2008). PEGylation: An Approach for Drug Delivery. A Review. Critical Reviews in Therapeutic Drug Carrier Systems. 25(5). 403–447. 154 indexed citations
16.
Chaurasia, Mohini, Manish K. Chourasia, Nitin Jain, et al.. (2008). Methotrexate Bearing Calcium Pectinate Microspheres: A Platform to Achieve Colon-Specific Drug Release. Current Drug Delivery. 5(3). 215–219. 22 indexed citations
17.
Jain, Aviral, Manish K. Chourasia, Vandana Soni, et al.. (2006). Brain-Specific Delivery of Rifampin from Lactyl Stearate-Coupled Liposomes via Monocarboxylic Acid Transporters. 4(1). 43–49. 5 indexed citations
18.
Chaurasia, Mohini, Manish K. Chourasia, Nitin Jain, et al.. (2006). Cross-linked guar gum microspheres: A viable approach for improved delivery of anticancer drugs for the treatment of colorectal cancer. AAPS PharmSciTech. 7(3). E143–E151. 131 indexed citations
19.
Jain, Rajesh K., Manish K. Chourasia, Akhilesh Jain, et al.. (2005). Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium. AAPS PharmSciTech. 6(1). E35–E41. 58 indexed citations
20.
Soni, Vandana, et al.. (2004). Novel Approaches For Drug Delivery To The Brain. Indian Journal of Pharmaceutical Sciences. 66(6). 711–720. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026